Interventional study to improve pertussis and influenza vaccination uptake in pregnant women

Eur J Obstet Gynecol Reprod Biol. 2024 Apr:295:201-209. doi: 10.1016/j.ejogrb.2024.02.019. Epub 2024 Feb 14.

Abstract

Objectives: Pertussis and influenza are endemic infections and associated with relevant morbidity and mortality in newborns and young infants. The Swiss Federal Office of Public Health has recommended influenza vaccination since 2011 and pertussis vaccination in pregnancy (ViP) since 2013 and expanded to repetition in each pregnancy since 2017. ViP is safe and effective in preventing severe diseases, but implementation is a challenge. We hypothesized that the proportion of women receiving ViP is persistently low despite existing national recommendations. Our primary objective was to compare the proportion of pertussis and influenza vaccine recommendations for and its acceptance by pregnant women before and after an information campaign tailored to obstetricians. Secondly, we aimed to identify reasons for missing or declining ViP.

Study design: We conducted a prospective, single-center, single-arm implementation study in the maternity ward at the University Women's Hospital Basel. We performed standardized interviews with women hospitalized for postpartum care before (October to December 2019, Phase 1, n = 262) and after an information campaign (October to December 2020, Phase 2, n = 233) and compared categorical variables using chi-squared or Fisher's exact test and continuous variables using Whitney Mann U test.

Results: We found no significant differences in the proportion of recommendation for pertussis ViP (80 % vs. 84 %, p = 0.25) and implementation (76 % vs. 78 %, p = 0.63) between Phase 1 and 2. Main reasons for missing or declining vaccinations were lack of recommendation (62.8 %) and safety concerns regarding the unborn child (17.7 %). In contrast, the proportion of recommendation for influenza ViP (45 % vs. 63 %, p < 0.001) and implementation (29 % vs. 43 %, p < 0.001) increased significantly.

Conclusion: Proactive recommendations by obstetricians play a key role in the implementation of ViP but is still insufficient in our setting. We believe that future efforts should aim to explore possible hurdles that impede recommendations by obstetricians for ViP. The focus should be on the needs and experiences of obstetricians in private practice, but also other health care professionals involved in care of pregnant women. Local campaigns do not seem effective enough, therefore national campaigns with new strategies are desirable.

Keywords: Antibody transfer; Cocooning; Immunization; Influenza; Pertussis; Pregnancy.

MeSH terms

  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Influenza Vaccines* / therapeutic use
  • Influenza, Human* / prevention & control
  • Patient Acceptance of Health Care
  • Pertussis Vaccine
  • Pregnancy
  • Pregnancy Complications, Infectious* / prevention & control
  • Pregnant Women
  • Prospective Studies
  • Surveys and Questionnaires
  • Vaccination
  • Whooping Cough* / prevention & control

Substances

  • Pertussis Vaccine
  • Influenza Vaccines